Table: Zeria Pharm -2021/22 parent results
May 11 (Reuters)-
Zeria Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 31.96 31.57
(+1.2 pct)
Operating 782 mln 390 mln
(+100.6 pct)
Recurring 1.59 1.09
(+46.4 pct)
Net 1.39 1.27
(+9.3 pct)
EPS 30.85 yen 27.65 yen
Ann Div 35.00 yen 34.00 yen 36.00 yen
-Q2 Div 17.00 yen 17.00 yen 18.00 yen
-Q4 Div 18.00 yen 17.00 yen 18.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T